| Literature DB >> 16580561 |
T J FitzGerald1, Jesse Aronowitz, M Giulia Cicchetti, Graeme Fisher, Sidney Kadish, Y C Lo, Charles Mayo, Shelagh McCauley, Joshua Meyer, Richard Pieters, Alexandra Sherman.
Abstract
As more patients are treated for their primary malignancy with cure or increased disease-free intervals, injury to normal tissues will become more detectable and an important endpoint for study. Future protocols will probably be modified based on toxicity endpoints. In Hodgkin's disease, current protocols use response-based treatment strategies to limit therapy. The objective is to provide the same level of tumor control and follow normal tissue endpoints for outcome analysis. DVH analysis has improved the ability to analyze endpoint data for normal tissues. These image-guided platforms will provide the infrastructure needed to continue efforts in improving the delivery of radiation therapy.Entities:
Mesh:
Year: 2006 PMID: 16580561 DOI: 10.1016/j.hoc.2006.01.005
Source DB: PubMed Journal: Hematol Oncol Clin North Am ISSN: 0889-8588 Impact factor: 3.722